Please login to the form below

Not currently logged in
Email:
Password:

premature ejaculation

This page shows the latest premature ejaculation news and features for those working in and with pharma, biotech and healthcare.

Forest Labs agrees $1.46bn deal to buy Furiex

Forest Labs agrees $1.46bn deal to buy Furiex

as well as Priligy (dapoxetine) for premature ejaculation.

Latest news

  • Menarini launches urology campaign in Greece Menarini launches urology campaign in Greece

    PE information push includes Not Just A Moment website. Menarini is supporting a new awareness initiative to educate men about premature ejaculation. ... women's satisfaction during sex, along with a range of information on premature ejaculation.

  • Menarini to raise awareness of sexual dysfunction Menarini to raise awareness of sexual dysfunction

    The new campaign – 'Firing Too Quickly' – is designed to raise awareness of premature ejaculation. ... We are delighted to launch 'Firing Too Quickly' and hope to support men (and their partners) in the management of premature ejaculation," commented

  • EMA backs drugs from Novo, Otsuka, AZ, Janssen, GSK EMA backs drugs from Novo, Otsuka, AZ, Janssen, GSK

    backed for the treatment of primary premature ejaculation in adult men.

  • Race to recovery

    Plethora. Plethora Solutions is in the news as the biotech company announced highly successful results for a final US phase III trial for PSD502, its premature ejaculation spray.

  • R&D news in brief

    Dapoxetine results. Results from a study published in The Lancet suggest that men suffering from moderate-to-severe premature ejaculation who received Johnson &Johnson's (J&J) experimental compound dapoxetine, experienced ... In two studies involving a

More from news
Approximately 1 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics